Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001144204-13-065661
Filing Date
2013-12-04
Accepted
2013-12-04 19:31:54
Documents
2
Period of Report
2013-11-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v362254_3a.html 3/A  
1 OWNERSHIP DOCUMENT v362254_3a.xml 3/A 9273
2 EXHIBIT 24 v362254_ex-24.htm EX-24 9180
  Complete submission text file 0001144204-13-065661.txt   20048
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address GRASMICK LUMBER 6715 QUAD AVENUE BALTIMORE MD 21237
Business Address
GRASMICK LOUIS J (Reporting) CIK: 0001261186 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-34058 | Film No.: 131258491